In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ncardia Cologne

Division of Ncardia Belgium

Latest From Ncardia Cologne

Deals Shaping the Medical Industry (04/08)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.


German start-up ATABIS GMBH focuses on identifying antigens implicated in oncogenesis and testing them for their ability to mobilize cytotoxic T cells, using a technique known as reverse immunology.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Gene Therapy, Cell Therapy
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Services
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Axiogenesis AG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Ncardia Belgium
  • Senior Management
  • Heribert Bohlen, MD, PhD, CEO
    Bernd Fronhoff, CFO & COO
  • Contact Info
  • Ncardia Cologne
    Phone: (49) 221 998818 0
    Nattermannalle 1
    Bldg. S20
    Cologne, 50829